May 6, 2020
SHORTEN YOUR DRUG DEVELOPMENT CYCLE BY IDENTIFYING AND CHARACTERIZING NEO-EPITOPE DIRECTLY FROM TISSUE USING MASS SPECTROMETRY
You might also be interested by
Infographics
Supporting Your Targeted Protein Degradation Strategies
January 31, 2023
Proteomics/Mass Spectrometry
More infoCellTalk
Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients
June 23, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info